Virology Testing Market is entering a period of strong expansion as healthcare systems place greater emphasis on early viral detection, disease surveillance, and accurate diagnosis. The market size is valued at USD 7.05 Billion in 2025 and is projected to reach USD 15.20 Billion by 2035, growing at a CAGR of 8.07% during the forecast period 2026–2035. Increasing cases of infectious diseases and broader access to advanced diagnostic technologies are supporting demand across hospitals, laboratories, research institutions, and other healthcare settings.
Modern virology testing has evolved beyond conventional laboratory methods, with PCR, serology, next-generation sequencing (NGS), CRISPR-based testing, and rapid diagnostic solutions playing increasingly important roles. The growing need for faster and more accurate identification of viral infections is encouraging healthcare providers to adopt technologies that can improve diagnostic efficiency while supporting clinical decision-making. According to the SNS Insider report, more than 3.54 billion virology tests were conducted in 2025, reflecting the scale of demand for viral testing worldwide.
Download the Sample Report: https://www.snsinsider.com/sample-request/10063
The rising prevalence of HIV, hepatitis, influenza, COVID-19, and other viral infections remains a major factor behind market growth. Healthcare organizations are also strengthening their ability to respond to emerging outbreaks, creating continued demand for reliable testing platforms. Increased attention to genomic surveillance and variant detection is further encouraging the use of advanced molecular methods, particularly NGS-based technologies.
PCR continues to hold a leading position among testing technologies because of its established accuracy, sensitivity, and broad clinical use. At the same time, newer approaches are opening additional avenues for market development. CRISPR-based testing is attracting attention for its potential to support rapid and accessible diagnostics, while decentralized and point-of-care testing solutions are gaining traction among healthcare providers seeking faster results closer to patients.
The market is also benefiting from the growing role of automation and artificial intelligence in diagnostic workflows. Automated systems can help laboratories handle larger testing volumes while improving consistency and operational efficiency. Meanwhile, bioinformatics platforms are becoming increasingly important as healthcare organizations manage larger datasets generated through genomic testing and surveillance programs.
Hospitals and clinics remain major users of virology testing solutions because of their role in infectious disease diagnosis and patient management. Diagnostic laboratories also represent a significant demand center, supported by continued investments in molecular testing infrastructure. The research and development segment is expected to provide additional growth opportunities as pharmaceutical and biotechnology companies increase their focus on antiviral therapies, vaccines, genomic research, and improved diagnostic technologies.
From a regional perspective, North America maintains a strong position, supported by developed healthcare infrastructure, widespread adoption of molecular diagnostics, and investment in innovative testing technologies. Asia-Pacific is emerging as an important growth market, with expanding healthcare infrastructure, increasing infectious disease surveillance, and rising adoption of PCR, NGS, and point-of-care testing. The SNS Insider analysis projects strong growth for the Asia-Pacific market during the forecast period.
Despite favorable growth prospects, high equipment costs, regulatory requirements, and shortages of skilled personnel can limit adoption, particularly in developing healthcare markets. Companies operating in the sector are therefore focusing on cost-efficient platforms, accessible testing solutions, automation, and strategic collaborations to broaden their reach.
As healthcare providers continue prioritizing early diagnosis and effective viral disease management, the virology testing industry is positioned for sustained development. Continued innovation in molecular diagnostics, rapid testing, genomic surveillance, and decentralized testing is expected to shape the competitive landscape and create new opportunities through 2035.
About Us
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.